The importance of tests applied to evaluate the effectiveness of antiplatelet therapy in patients with recurrent coronary stent thrombosis | Zendy

Aleksandra Grdinić | Zendy; Danilo Vojvodić | Zendy; Vesna Ilić | Zendy; Zvonko Magić | Zendy; Nina Djukanović | Zendy; Mina Radovanović | Zendy; Predrag Miljić | Zendy; Slobodan Obradović | Zendy; Ivana Majstorović | Zendy; Bojana CikotaAleksić | Zendy; Miodrag Ostojić | Zendy

Open Access

The importance of tests applied to evaluate the effectiveness of antiplatelet therapy in patients with recurrent coronary stent thrombosis

Author(s) -

Aleksandra Grdinić,

Danilo Vojvodić,

Vesna Ilić,

Zvonko Magić,

Nina Djukanović,

Mina Radovanović,

Predrag Miljić,

Slobodan Obradović,

Ivana Majstorović,

Bojana CikotaAleksić,

Miodrag Ostojić

Publication year - 2009

Publication title -

vojnosanitetski pregled

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.123

H-Index - 19

eISSN - 2406-0720

pISSN - 0042-8450

DOI - 10.2298/vsp0904328g

Subject(s) - clopidogrel , p2y12 , thienopyridine , medicine , percutaneous coronary intervention , ticlopidine , aspirin , thrombosis , stent , platelet , coronary stent , cardiology , platelet activation , conventional pci , myocardial infarction , restenosis

Stent thrombosis is potentially lethal complication with huge economic burden. The role of insufficient response to antiplatelet therapy is still unclear reason for its occurrence.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research